What Unites Congress? Scorn For Shkreli
Washington — A smirking Martin Shkreli briefly united Democrats and Republicans on Capitol Hill last week, as lawmakers took turns blasting the price-hiking former CEO who has become the new poster child for corporate greed. But the gridlocked state of Congress virtually assures federal efforts to lower drug prices will remain in limbo for years. And even then, experts warn that the options available to Congress would not stop...
Senate Probing Drug Price Spikes
Washington — A Senate committee has launched an investigation into exorbitant drug price hikes by Turing Pharmaceuticals and three other companies, responding to public anxiety over rising prices for critical medicines. The Senate’s special committee on aging requested documents and information Wednesday from Turing, Valeant Pharmaceuticals and two other drugmakers already under scrutiny for recent price spikes. Notably, the senators...
Uproar Puts Drug Pricing in Spotlight
Martin Shkreli is health care’s Gordon Gekko, its wolf of Wall Street, the symbol of all that makes people uneasy about an industry that seeks to make money by selling treatments while vowing to care only about the well-being of vulnerable patients. For days, a seething social media mob backed by an opportunistic politician or two has hammered the swaggering, 32-year-old “pharma bro” who jacked up the price of an obscure but critical...
